Fixed-dose combination of abacavir, lamivudine and zidovudine for HIV therapy

ISSN： 1746-0794

Source： Future Virology, Vol.2, Iss.1, 2007-01, pp. : 23-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abacavir/lamivudine fixed-dose combination tablet for the treatment of HIV-1 infection

By Taylor Clare L Wilkins Edmund GL

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 11-21

Future Medicine

Access to resources Recommend Favorite

Lamivudine/Zidovudine/Abacavir: Triple Combination Tablet

By Ibbotson T. Perry C.M.

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1089-1098

Adis International

Access to resources Recommend Favorite

WHO endorses fixed-dose triple combination HIV therapy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 438, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Dolutegravir, abacavir and lamivudine as HIV therapy

By Fernandez-Montero Jose Vicente Barreiro Pablo Labarga Pablo De Mendoza Carmen Soriano Vicente

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1051-1057

Informa Healthcare

Access to resources Recommend Favorite

Simultaneous And Extended Delivery Of Stavudine, Lamivudine And Nevirapine In Fixed Dose Combination Using Sandwiched Osmotic Tablets For Hiv Therapy

Current Drug Delivery, Vol. 12, Iss. 5, 2015-10 ,pp. : 600-612

Bentham Science Publishers

Access to resources Recommend Favorite